Treatment of paediatric cerebral palsy with Dysport.

Abstract

Dysport (Clostridium botulinum type A toxin-haemagglutin complex) has had its licence extended to include treatment of children aged 2 years and over with dynamic equinus foot deformity, caused by spasticity associated with cerebral palsy. Dysport reduces muscle tone, thus improving function, relieving pain, and facilitating physiotherapy, application and tolerability of splints.

• Authors: T Ubhi
• Journal: Hospital medicine (London, England : 1998) (Hosp Med) Vol. 61 Issue 10 Pg. 718-21 (Oct 2000) ISSN: 1462-3935 [Print] England
• PMID: 11103284 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Anti-Dyskinesia Agents
• Drug Combinations
• Hemagglutinins
• Botulinum Toxins, Type A

Topics

• Adolescent
• Anti-Dyskinesia Agents (pharmacology)
• Botulinum Toxins, Type A (therapeutic use)
• Cerebral Palsy (drug therapy, physiopathology)
• Child
• Child, Preschool
• Drug Combinations
• Hemagglutinins (therapeutic use)
• Humans
• Infant
• Muscle Spasticity (drug therapy)